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ABSTRACT 
The specific aims of this study is to synthesize and to study 
the possible mechanism of N’-benzoylsalicylhydrazide derivatives 
as an antituberculosis agent through InhA (Enoyl acyl carrier 
protein reductase) inhibition using in silico method. Five analogues 
of N’-benzoylsalicylhydrazide were synthesized using microwave 
irradiation from methyl salicylate as starting material, which 
yielded 80-90% product on average. This indicates a considerable 
improvement in terms of effectivity and efficiency, compared to 
the more conventional method using reflux condition. Character-
ization of the compounds were subsequently carried out by UV, 
FTIR, 1H-NMR, 13C-NMR spectroscopy, which confirmed that the 
compounds had been successfully synthesized. Ultimately, 
molecular docking was performed using Molegro Virtual Docker 
(MVD) on the active site of InhA enzyme to predict the activity of 
the compounds. The results showed that all compounds 
performed comparatively well against N-(4-Methylbenzoyl)-4-
benzylpiperidine as the native ligand and also yielded lower 
docking score than isoniazide (INH). From this study it can be 
concluded that N’-benzoylsalicylhydrazide derivatives could be 
synthesized using microwave irradiation with good product yield 
and all of the synthesized analogues are suggested to possess 
antituberculosis activity via InhA enzyme inhibition. In vitro 
activity will have to be determined in the future to validate 
whether N’-benzoylsalicylhydrazide derivatives perform well as a 
potential antituberculosis agent. 
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INTRODUCTION  
Lower respiratory tract infections were 
one of the top 10 deadliest diseases in 2010-
2015. Several types of these diseases such as 
pneumonia, bronchitis, tuberculosis were 
ranked among the top 10 deadliest diseases in 
the world. According to WHO data, lower 
respiratory tract infections account for around 
5.7% of deaths in the world or around 3.2 
million people died in 2015 (Pietrangelo and 
Holland, 2018). One of the lower respiratory 
tract infections that has become a concern for 
medicals and researchers is tuberculosis 
infection. Tuberculosis infection accounts for 
half of the total mortality from lower 
respiratory tract infections. Therefore, this 
disease still ranks 9th out of the list of the top 
10 deadliest diseases in the world. Based on 
data from the WHO in 2015 around 1.3 million 
(2.4%) people died from this infection 
(Pietrangelo and Holland, 2018). Indonesia, as 
one of the most populated developing country 
in the world, is still facing this challenge. Based 
on the recent data in 2007-2013, the lower 
respiratory tract infections occurred frequently, 
with no significant change in the number of 
prevalence observed during this period 
(Indonesian Ministry of Health, 2103). 
Mycobacterium tuberculosis had been 
found to be resistant to tuberculosis treatment 
with rifampin and isoniazid (INH) which is 
often referred to as multi-drugs resistance 
(MDR). Many cases of MDR has occurred 
during the treatment using rifampin and 
isoniazid as the main therapy (Dipiro et al., 
2008). Rifampin possesses bactericidal 
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mechanism against Mycobacterium tuberculosis 
as it binds strongly to the β-subunit of bacterial 
DNA-dependent RNA polymerase and thereby 
inhibits RNA synthesis (Katzung et al., 2009). 
Resistance against rifampin can be caused by 
one of the several possible point mutations in 
rpoB, the gene for the β-subunit of RNA 
polymerase. These mutations prevent binding 
of rifampin to RNA polymerase (Katzung et al., 
2009). As for Isoniazid (INH), its mechanism 
as antituberculosis against Mycobacterium 
tuberculosis is via inhibition of mycolic acids 
synthesis, which plays an important role as 
major components of mycobacterial cell walls. 
Isoniazid is a prodrug that is activated by KatG, 
the mycobacterial catalase-peroxidase. The 
activated form of isoniazid exerts its lethal 
effect by forming a covalent complex with an 
acyl carrier protein (AcpM) and KasA, a β-
ketoacyl carrier protein synthetase, which 
blocks mycolic acid synthesis (Katzung et al., 
2009). Resistance to isoniazid has been 
associated with mutations resulting in 
overexpression of InhA, which encodes an 
NADH-dependent acyl carrier protein 
reductase; mutation or deletion of KatG, 
promote mutations resulting in overexpression 
of ahpC. The existence of mutations in KatG 
expresses high levels of resistance in isoniazid 
(Katzung et al., 2009). 
To overcome MDR problems, it is 
necessary to develop new drugs to reduce the 
high cases of MDR in tuberculosis infections. 
Isoniazid has a simpler chemical structure 
compared to rifampin, therefore it is easier to 
develop this compound to overcome resistance 
in isoniazid. Some of hydrazide derivatives 
were reported to have antibacterial (Maheswari 
et al., 2015; Kumar et al., 2014; Thomas et al., 
2014) and antituberculosis activity (Maheswari 
et al., 2015; Lourenço et al., 2011). In this study, 
we synthesize five compounds of             N’-
benzoylsalicylhydrazide derivatives (Figure 1). 
Based on retrosynthetic analysis (Figure 2),            
we proposed to synthesize N'-
benzoylsalicylhydrazide derivatives from methyl 
salicylate, hydrazine hydrate and benzoyl 
chloride as starting materials. Methyl salicylate 
would be reacted with hydrazine hydrate to 
produce an acylhydrazide compound, which 
subsequently   reacted  with benzoyl chloride to  
yield the final products. Previous study in 
hydrazide derivative synthesis indicates stirring 
method at room temperature for 30min, while 
some others suggest the application of 
microwave irradiation (450-900watts) for 30-
180s (Widiyana et al., 2017). In this study, we 
applied microwave irradiation on the first stage 
of the reaction to obtain the optimal of time 
and product yield. 
 
 
 
Figure 1. Isoniazid (a) and N’-benzoylsalicylhy-
drazide derivatives  (b) chemical structure. 
 
 
 
Figure 2. Retrosynthetic analysis of N’-
benzoylsalicylhydrazide derivatives 
 
MATERIAL AND METHODS 
All reagents such as methyl salicylate, 
hydrazine, some of benzoyl chloride derivatives 
and all solvent such as THF were purchased 
from standard commercial suppliers. Reactions 
were monitored with TLC  using  pre-coated  
aluminum  sheets  with  GF254  silica  gel,  
0.2mm  layer  thickness  (E.Merck). Mobile 
phase used for TLC were chloroform: ethyl 
acetate (3:1) and the spots were visualized in 
UV chamber under UV light 254nm. Melting 
points of  the  synthesized  compounds  were  
measured  with  an  Sybron Thermolyne            
MP 12615 melting  point  apparatus. UV                
spectra were obtained using Shimadzu UV-
1800 spectrophotometer. IR spectra were 
obtained using a Perkin Elmer Spectrum 
spectrophotometer using KBr disks. 1H-NMR 
and 13C-NMR spectra were obtained on JEOL 
JNM-ECS400 (1H-NMR: 400MHz, 13C-NMR:  
100 MHz). Deuterated DMSO was used as 
solvent for these analysis.  
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General synthesis 
Synthesis process to obtained N’-
benzoylsalicylhydrazide derivatives on this 
study (Figure 3). The first stage of reaction, 
methyl salicylate was reacted with hydrazine 
hydrate to obtanined Salicylbenzohydrazide. 
The second stage of reaction, Salicylbenzohy-
drazide was reacted with some of benzoyl 
chloride derivatives to obtained N’-
benzoylsalicylhydrazide derivatives. The detail 
of condition of reaction is explain in the 
subsequent part. 
 
Synthesis of Compound 1 
(Salicylbenzohydrazide)  
Methyl salicylate (10mmol) was reacted 
with hydrazine hydrate (80%, 20mmol) and 
homogenized with magnetic stirrer. The 
mixture was heated in microwave irradiation at 
360W for 3min until a solid mass was formed. 
The mixture was then cooled and distilled water 
(10mL) was added to the mixture. The 
separated solid was collected by filtration. The 
solid mass was crystallized by ethanol 96% to 
obtain Compound 1. 
 
Synthesis of Compounds 2a-e (N’-
benzoylsalicylhydrazide derivatives) 
Compound 1 (8.5mmol) was added with 
10 mL of THF as solvent and homogenized 
with magnetic stirrer. The mixture was then 
added by benzoyl chloride derivatives (9mmol) 
dropwise with constant stirring at 0ºC for 
30min, before the addition of 10% sodium 
bicarbonate solution. The latter was performed 
until the effervescence process ceased. The 
separated solid was allowed to settle down 
before filtered off. Ultimately, the solid was 
crystallized by ethanol 96% to obtained 
compound 2a-e. 
 
Molecular docking study 
This study was performed in notebook 
equipped with processor AMD A9-9420 
Radeon R5, RAM 4.00 GB and 64 bit operating 
system. Molegro Virtual Docker (MVD) ver 5.5 
(CLC Bio) was utilized for molecular docking 
and CS ChemBioDraw Ultra ver 11.0 
(Cambridge Soft)   was   used to prepare our 
compounds (2a-e) prior to docking process. 
The structure of InhA protein (PDB ID: 
2NSD) was obtained from the Protein Data 
Bank (www.rcsb.org) (Xin et al., 2007). 
Compounds 2a-e structures were built with   
ChemBioDraw   Ultra   11.0   and   their 
geometry optimization were performed using 
MMFF94 (Halgren, 1996). The validation of 
docking was carried out by redocking the native 
ligand of the enzyme (N-(4-Methylbenzoyl)-4-
benzylpiperidine) into its active site. Criteria of 
acceptance is set with the value of Root Mean 
Square Deviation (RMSD) below 2.0 Å (Figure 
4). After redocking process, the compounds 2a-
e were docked into active site of InhA enzyme. 
The binding affinity  between  ligand and  
enzyme  (docking  score) was evaluated using 
Rerank Score, and we also compared the score 
of the native ligand with our compounds. 
Rerank Score is one of the evaluation method 
of docking pose which is based on MolDock 
Score with some adjustments in the weight of 
each terms of the score. In addition, sp2-sp2 
torsion and Lenard-Jones 12-6 potential were 
also introduced to further improve the accuracy 
 
 
Figure 3. Synthesis of N’-benzoylsalicylhydrazide derivatives 
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of docking score (Thomsen and Christensen, 
2006). Low score means smaller amount                
of  energy  required  in  forming   drug-receptor 
interaction which leads to an assumption that 
the compound is more suitable to occupying 
active site of the receptor. 
 
RESULT AND DISCUSSION 
The reaction of methyl salicylate with 
hydrazine was performed by applying 
microwave irradiation at 360W for 3min. This 
procedure yielded (1) via nucleophilic addition 
of hydrazine (-NH2) to the electrophilic 
carbonyl group of the ester group (methyl 
salicylate) (Figure 5). The reaction of compound 
(1) with some of benzoyl chloride derivatives 
(4-methoxy benzoyl chloride; 4-chloro benzoyl 
chloride; 2,4-dichloro  benzoyl chloride;  3,4-
dichloro  benzoyl  chloride) under water-free 
condition has successfully yielded several 
benzohydrazide derivatives (compounds 2a-e).  
The mechanism of this reaction is the addition 
of nucleophilic (-NH2) compound (1) to the 
electrophilic carbonyl group of the acyl 
carbonyl groups though SNacyl mechanism 
(Figure 6).  
 
Compound 1 (Salicylbenzohydrazide) 
Obtained in white powders (85 %), mp : 
UV λmax (nm) : 233; FTIR (KBr) cm-1 : 3320 (-
OH); 3270 (-NH); 3055 (C-H sp2); 1647 (C=O); 
1586 and 1485 (C=C aromatic); 1351 (C-N). 
1H-NMR (400 MHz, DMSO-d6, δ, ppm): δ 
12.48 (1H, s); δ 10.07 (2 H, s); δ 7.80 (1 H, d, 9, 
1 Hz); δ 7.37 (1 H, t, 8.8 Hz); δ 6.89 ( 1H, d, 
8.5 Hz); δ 6.85 (1H; t, 8.1 Hz); δ 4.66 (1 H, s). 
 
Compound 2a (N'-benzoyl-2-hydroxy-
benzohydrazide) 
Obtained in white crystals (85 %), mp : 
239-240 oC, UV λmax (nm) : 302; FTIR (KBr) 
cm-1 : 3302 (-OH); 3270 (-NH); 1655 (C=O); 
1586  and  1485   (C=C aromatic);   1387(C-N).    
 
 
Figure 4. Comparison of its native ligand (green) with  the doking result simulation (purple) by 
Molegro Virtual Docker (MVD) software Ver.5.5. The RMSD is 0.45Å 
 
 
 
Figure 5. The mechanism reaction of the addition of nucleophilic hydrazine (-NH2) to the 
electrophilic carbonyl group of the ester group 
 
Figure 6. The mechanism reaction of the addition of nucleophilic (-NH2) compound (1) to the 
electrophilic carbonyl group of the acyl carbonyl groups 
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1H-NMR (400MHz, DMSO-d6, δ, ppm) : δ 
11.91 (1H, s); δ 10.65 (2H, s); δ 7.89 (3 H, d, 10 
Hz); δ 7.58 (1 H, t, 9.2 Hz); δ 7.51-7.41 (3 H, 
m); δ 6.95- 6.90 (2H, m); 13C-NMR (100 MHz, 
DMSO-d6, δ, ppm) : δ 168.3; δ 1661.1; 159,8; δ 
134,7; δ 132.8; δ 129.1 (2C); δ 128.8; δ 128.0 
(2C); δ 119.6; δ 117.9; δ 115.0. All these 
spectral data are in agreement with the 
structure of compound N'-benzoyl-2-
hydroxybenzohydrazide 
 
Compound 2b (2-hydroxy-N'-(4-
methoxybenzoyl)benzohydrazide) 
Obtained in white powders (82 %), mp : 
215-216ºC ; UV λmax (nm) : 301; FTIR (KBr) 
cm-1 : 3309 (-OH); 3270 (-NH); 3054 (C-H 
sp2); 1606 (C=O); 1586 and 1483 (C=C 
aromatic); 1284 (C-O); 1264 (C-N); 1174 (-CH 
sp3); 1H-NMR (400 MHz, DMSO-d6, δ, ppm) : 
δ 11.93 (1 H, s); δ 10,60 (1H, s); δ 10,49 (1H, 
s); 7,90-7,86 (3 H, m); δ 7.44-7.40 (1 H, m); δ 
7.15 (1 H, d, 11,5 Hz); 6.94-6.92 (2H, m); δ 
3.79 (3H, s); 13C-NMR (100 MHz, DMSO-d6, 
δ, ppm) : δ 168.4; δ 155.6; δ 162.6; δ 134.7; δ 
129.9 (2C); δ 128.7; δ 124.9; δ 119.6; δ 117.9; δ 
115.0; δ 114.3 (2C); δ 55.9. All these            
spectral data are in agreement with the 
structure of compound 2-hydroxy-N'-(4-
methoxybenzoyl)-benzohydrazide. 
 
Compound 2c (N'-(4-chlorobenzoyl)-2-
hydroxybenzohydrazide)  
Obtained in white crystals (92%), mp : 
233-234ºC, UV λmax (nm) : 302; FTIR (KBr) 
Table I. Molecular docking result on InhA protein 
Compound 
Rerank score 
(kcal/mol) 
Docked 
Pose 
Hydrogen 
bond 
Residues 
involved 
Steric 
interaction 
Residues 
involved 
 
4PI 
-97.86 √ 1 Ile 194 2 
Ala 157 
Ile 202 
 
INH 
-29.67 √ 2 
Ile 194 
Thr 196 
3 
Asp 148 
Ala 191 
Met 99 
 
(2a) 
-88.52 
√ 
 
1 
Ile 194 
 
- - 
 
(2b) 
-94.56 
√ 
 
- - 4 
Phe 149 
Tyr 158 
Pro 193 
Glu 219 
 
(2c) 
-80.84 
√ 
 
1 Ile 194 1 Ala 157 
 
(2d) 
-92.82 
√ 
 
- - 3 
Met 155 
Met 199 
Glu 219 
 
(2e) 
-89.21 
√ 
 
1 Ile 194 1 Leu 218 
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cm-1 : 3259  (-OH);  3270 (-NH); 1607 (C=O); 
1565 and 1475 ( C=C aromatic); 1175 (C-N); 
737 (C-Cl);  1H-NMR (400MHz, DMSO-d6, δ, 
ppm) : δ 11.85 (1H, s); δ 10.90 (1H, s); δ 10.75 
(1H, s); δ 7.89 (3 H, t, 10,2 Hz); δ 7.58 (2H, d, 
11.0 Hz); δ 7.42 (1H, t, 8.7 Hz); δ 6.95-6.92 
(2H, m);   13C-NMR (100 MHz, DMSO-d6, δ, 
ppm) : δ 168.1; δ 165.1; δ 159.7; δ 137.4; δ 
134.7; δ 131.5; δ 129.9 (2C); δ 129.2 (2C); δ 
128.9; δ 119.6; δ 117.9; δ 115.1.  All these 
spectral data are in agreement with the 
structure of compound N'-(4-chlorobenzoyl)-2-
hydroxy-benzohydrazide. 
 
Compound 2d (2,4-dichloro-N'-(2-
hydroxybenzoyl)benzohydrazide) 
Obtained in white crystals (81%), mp : 
236-238 oC, UV λmax (nm) : 294; FTIR (KBr) 
cm-1 : 3321 (-OH); 3290 (-NH); 3065 (C-H 
sp2); 1635 (C=O); 1607 and 1475 (C=C 
aromatic); 1375 (C-N); 571 (C-Cl); 1H-NMR 
(400MHz, DMSO-d6, δ, ppm) : δ 11.87 (1H, s); 
δ 10.75 (1H, s); δ 10.71 (1H, s), δ 7.85 (1H, d, 
10.0 Hz); δ 7.73 (1 H, s); δ 7.55-7.41 (3 H, m); 
δ 6.96-6.90 (2 H. m); 13C-NMR (100 MHz, 
DMSO-d6, δ, ppm) : δ 167.7; δ 164.9; δ 159.6; 
δ 135.9; δ 134.8; δ 133.7; δ 132.3; δ 131.3; δ 
130.1; δ 129.0; δ 128.0; δ 117.9; δ 115.0. All 
these spectral data are in agreement with the 
structure of compound 2,4-dichloro-N'-(2-
hydroxybenzoyl)benzohydrazide. 
 
Compound 2e (3,4-dichloro-N'-(2-
hydroxybenzoyl)benzohydrazide) 
Obtained in white crystals (93%), mp : 
249-241 oC, UV λmax (nm) : 300; FTIR (KBr) 
cm-1 : 3190 (-OH); 3120 (-NH); 1606 (C=O); 
1504 and 1470 (C=C aromatic); 1382 (C-N); 
642 (C-Cl); 1H-NMR (400MHz, DMSO-d6, δ, 
ppm) : δ 11.80; δ 10.89; δ 10.70; δ 8.11 (1H, d, 
3.0 Hz); δ 7.86-6.94 (6 H, m); 13C-NMR (100 
MHz, DMSO-d6, δ, ppm) : δ167.9; δ 163.8; δ 
159.5; δ 135.4; 134.8; δ 133.1; δ 132.1; δ 131.6; 
129.9; δ 129.0; δ 128.3; δ 119.7; δ 117.9; δ 
115.2 All these spectral data are in agreement 
with the structure of compound 3,4-dichloro-
N'-(2-hydroxybenzoyl) benzohydrazide 
 
Molecular docking study 
Compounds 2a-e were docked in to the 
active site of enoyl acyl carrier protein 
reductase (InhA) This enzyme was chosen, 
since it catalyzes the reduction of long-chain 
trans-2-enoyl-ACP in the type II fatty acid 
biosynthesis pathway of Mycobacterium 
tuberculosis.  Inhibition of InhA disrupts the 
biosynthesis of the mycolic acids that were 
main component of the mycobacterial cell wall. 
The mechanism of action of isoniazid is via 
inhibition of the enzyme. However, 
Mycobacterium tuberculosis has been found to 
be resistant to isoniazid. Compounds 2a-e are 
N'-benzoyl-2-hydroxybenzohydrazide erivatives 
that were developed are found to    be similar 
with isoniazid. Thus, compounds 2a-e were 
suggested to be potent to inhibit InhA. 
Based on molecular docking result 
(Table I; Figure 7), it is shown that compounds 
2a-e have lower docking score (-94.56 to               
-80.84kcal/mol) than isoniazid (-29.67kcal/mol) 
and some of the compounds possess comparable 
score to N-(4-Methylbenzoyl)-4-benzyl-piperidine 
(-97.86kcal/mol). Interaction between native 
ligand and isoniazid with InhA showed a 
hydrogen bond with Ile 194 residues and some 
steric interactions on residues such as Ala 157 
and Ile 202. Compound 2a; 2c; 2e were 
predicted to form hydrogen bond interaction 
with Ile 194 and some steric interaction. 
Hydrogen bond on Ile 194 residue was predicted 
as one of the most important interaction for a 
ligand to inhibit InhA activity. Both                        
N-(4-Methylbenzoyl)-4-benzylpiperidine and 
isoniazid interact with this residue in 
aforementioned manner. Based on the results 
of docking score and analysis of hydrogen 
bond    and    steric   interactions    with   InhA,  
 
compound 2a-e were suggested to have 
antituberculosis activity through the mechanism 
of inhibition of InhA enzyme. This prediction 
can be used as a foundation for further 
investigation in enzymatic and other in vitro 
assay. 
 
CONCLUSION 
The method to obtain N'-benzoyl-2-
hydroxybenzohydrazide derivatives by 
microwave irradiation is more time efficient 
with satisfactory product yield (80-90%). 
Compounds 2a-e are suggested to possess 
antituberculosis activity by inhibiting InhA 
enzyme based on molecular docking that have 
been conducted. 
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